# X-Energy, Inc.: financial statements, quarterly

XE · Nasdaq · CIK 2088896 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/xe.md) · [Financials](/companies/xe/financials.md) · [Filings](/companies/xe/filings.md) · [Insiders](/companies/xe/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/xe/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Revenue | $m | [20.8](/filings/0001193125-26-256376.md) | [21.5](/filings/0001193125-26-347752.md) | [43.4](/filings/0001193125-26-256376.md) | [54.6](/filings/0001193125-26-347752.md) |
| Cost of revenue | $m | [28.7](/filings/0001193125-26-256376.md) | [36.1](/filings/0001193125-26-347752.md) | [65.4](/filings/0001193125-26-256376.md) | [86.7](/filings/0001193125-26-347752.md) |
| Research and development | $m | [0.4](/filings/0001193125-26-256376.md) | [0.8](/filings/0001193125-26-347752.md) | [0.1](/filings/0001193125-26-256376.md) | [0.2](/filings/0001193125-26-347752.md) |
| Selling, general and administrative | $m | [18.0](/filings/0001193125-26-256376.md) | [27.3](/filings/0001193125-26-347752.md) | [44.1](/filings/0001193125-26-256376.md) | [77.7](/filings/0001193125-26-347752.md) |
| Operating income | $m | [(26.3)](/filings/0001193125-26-256376.md) | [(42.8)](/filings/0001193125-26-347752.md) | [(66.1)](/filings/0001193125-26-256376.md) | [(110)](/filings/0001193125-26-347752.md) |
| Interest expense | $m | [0.1](/filings/0001193125-26-256376.md) | [0.4](/filings/0001193125-26-347752.md) | [0.0](/filings/0001193125-26-256376.md) | [0.0](/filings/0001193125-26-347752.md) |
| Net income | $m | [(10.2)](/filings/0001193125-26-256376.md) | [0.0](/filings/0001193125-26-347752.md) | [(166)](/filings/0001193125-26-256376.md) | [(59.1)](/filings/0001193125-26-347752.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Net income: us-gaap:NetIncomeLoss

## Balance sheet

| Line item | Unit | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | period not labelled (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | [459](/filings/0001193125-26-347752.md) | [224](/filings/0001193125-26-256376.md) | [1,145](/filings/0001193125-26-347752.md) |
| Current assets | $m | not reported | not reported | not reported | [854](/filings/0001193125-26-347752.md) | [774](/filings/0001193125-26-256376.md) | [1,794](/filings/0001193125-26-347752.md) |
| Total assets | $m | not reported | not reported | not reported | [1,211](/filings/0001193125-26-347752.md) | [1,196](/filings/0001193125-26-256376.md) | [2,255](/filings/0001193125-26-347752.md) |
| Current liabilities | $m | not reported | not reported | not reported | [58.8](/filings/0001193125-26-347752.md) | [89.3](/filings/0001193125-26-256376.md) | [104](/filings/0001193125-26-347752.md) |
| Total liabilities | $m | not reported | not reported | not reported | [369](/filings/0001193125-26-347752.md) | [150](/filings/0001193125-26-256376.md) | [160](/filings/0001193125-26-347752.md) |
| Long-term debt | $m | not reported | not reported | not reported | [0.0](/filings/0001193125-26-347752.md) | [0.0](/filings/0001193125-26-256376.md) | [0.0](/filings/0001193125-26-347752.md) |
| Shareholders' equity | $m | [(847)](/filings/0001193125-26-256376.md) | [(857)](/filings/0001193125-26-256376.md) | [(940)](/filings/0001193125-26-347752.md) | [(1,224)](/filings/0001193125-26-347752.md) | [(1,386)](/filings/0001193125-26-256376.md) | [1,815](/filings/0001193125-26-347752.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(41.9)](/filings/0001193125-26-256376.md) | [(20.0) d](/filings/0001193125-26-347752.md) | [(67.3)](/filings/0001193125-26-256376.md) | [(97.3) d](/filings/0001193125-26-347752.md) |
| Capital expenditure | $m | [11.2](/filings/0001193125-26-256376.md) | [24.4 d](/filings/0001193125-26-347752.md) | [43.0](/filings/0001193125-26-256376.md) | [63.3 d](/filings/0001193125-26-347752.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. No prices; not investment advice.